Protocols
1 protocol(s) meet the specified criteria
Drug: PF-02341066
Protocol No.TitleStatus
A8081001Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of PF-02341066, A C-Met/HGRF Selective Tyrosine Kinase Inhibitor, Administered Orally to Patients with Advanced Cancer Open